This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignees: Reckitt Benckiser Inc., Adams Laboratories, Inc.. Active years: 2002-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2011
Title: **The Innovative Mind of Robert D. Davis: A Trailblazer in Pharmaceutical Patents**
Introduction
Robert D. Davis, an accomplished inventor based in Arlington, TX, has made significant contributions to the pharmaceutical industry through his innovative inventions. With a total of six patents to his name, Davis has focused on enhancing the effectiveness and bioavailability of pharmaceutical formulations, particularly in the realm of combination drugs. His work demonstrates a strong commitment to improving therapeutic options for patients.
Latest Patents
Among his latest patents, Davis developed a **sustained release formulation of guaifenesin combined with dextromethorphan**. This novel pharmaceutical formulation utilizes a blend of hydrophilic and water-insoluble polymers, specifically hydroxypropyl methylcellulose and acrylic resin, to achieve optimal drug release characteristics. The formulation allows for effective bioavailability of guaifenesin for at least twelve hours, promising crucial therapeutic benefits for users.
Additionally, he holds a patent for a **sustained release formulation of guaifenesin in combination with pseudoephedrine**. Similar to the previous invention, this formulation is designed to enhance the pharmacokinetic profile of guaifenesin, ensuring its availability in the patient's system over an extended period. This innovation demonstrates Davis's ability to marry scientific research with practical applications in medicine.
Career Highlights
Throughout his career, Robert D. Davis has worked with reputable companies in the pharmaceutical sector, including Reckitt Benckiser Inc. and Adams Laboratories, Inc. His role in these organizations has allowed him to contribute to the development of breakthrough products aimed at improving the efficacy of over-the-counter medications.
Collaborations
Davis has collaborated with notable colleagues such as Ralph W. Blume and Donald Jeffrey Keyser. These partnerships have fostered an environment of innovation and creativity, allowing them to tackle complex challenges in drug formulation together. Their combined knowledge and expertise have greatly influenced advancements in pharmaceutical formulations.
Conclusion
Robert D. Davis exemplifies the spirit of innovation through his commitment to developing effective pharmaceutical formulations. His six patents reflect his dedication to improving patient outcomes and enhancing medication efficacy. As he continues to contribute to the field, Davis remains a key figure in the landscape of pharmaceutical inventions, inspiring both current and future inventors in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
